Contact this trialFirst, we need to learn more about you.
Anti-amyloid agent
AGB101 for Mild Cognitive Impairment
Recruiting0 awardsPhase 2
Baltimore, Maryland
This trial aims to test if AGB101 can help slow down memory loss and functional decline in individuals with mild cognitive impairment due to Alzheimer's Disease. Participants will either receive a placebo or AGB101
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service